Document is current
Any future updates will be listed below
-
Authors
Kale, Ajinath
Lech, Maciej
Anders, Hans-Joachim
Gaikwad, Anil Bhanudas https://orcid.org/0000-0003-4627-5504
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (AN372/29-1)
Deutsche Forschungsgemeinschaft (30-1)
- License Information
-
More Information
Article History
Accepted: 19 March 2023
First Online: 24 April 2023
Declarations
:
: Hans-Joachim Anders received speaker fees and consultancy honorariums from GSK, AstraZeneca, Janssen, Otsuka, Kezar, and Novartis. Ajinath Kale, Maciej Lech, and Anil Bhanudas Gaikwad declare they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: AK conducted literature research and wrote the manuscript; HJA co-wrote and participated in designing the manuscript, edited the manuscript, and prepared it for submission. Anil Bhanudas Gaikwad reviewed and drafted the manuscript. All authors read and approved the final version of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
